A. Wahlén
Impact in
- Toxicology top 1%
- Forensic Toxicology and Drug Analysis
- Pharmacology top 1%
- Cannabis and Cannabinoid Research
Papers in
-
- Cannabis and Cannabinoid Research 4
- Pharmacogenetics and Drug Metabolism 1
-
- Forensic Toxicology and Drug Analysis 3
- Co-authors
- Stig Agurell (3 shared papers)Leo E. Hollister (3 shared papers)Annika Ohlsson (2 shared papers)J.‐E. Lindgren (2 shared papers)H. K. Gillespie (2 shared papers)Lars Farde (3 shared papers)Paul Jansson (1 shared paper)F.‐A. Wiesel (1 shared paper)
- Journals
- Clinical Pharmacokinetics (1 paper)Journal of Mass Spectrometry (1 paper)Acta Anaesthesiologica Scandinavica (1 paper)The Journal of Clinical Pharmacology (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- SwedenUnited StatesFinland
In The Last Decade
A. Wahlén
10 papers receiving 697 citations
Peers
Comparison fields: 5 of 78
- Toxicology 165
- Pharmacology 528
- Cellular and Molecular Neuroscience 205
- Biological Psychiatry 15
- Psychiatry and Mental health 88
Countries citing papers authored by A. Wahlén
This map shows the geographic impact of A. Wahlén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Wahlén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Wahlén more than expected).
Fields of papers citing papers by A. Wahlén
This network shows the impact of papers produced by A. Wahlén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Wahlén. The network helps show where A. Wahlén may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Wahlén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1980 | 361 | |
| 2 | 1981 | 124 | |
| 3 | 1988 | 94 | |
| 4 | 1982 | 78 | |
| 5 | 1981 | 32 | |
| 6 | 1989 | 15 | |
| 7 | Plasma levels of delta 9-tetrahydrocannabinol after intravenous, oral, and smoke administration. | 1981 | 13 |
| 8 | Placebo in clinical drug trials--a multidisciplinary review. | 1982 | 13 |
| 9 | 1992 | 10 | |
| 10 | Influence of food intake on the bioavailability of zimeldine and its active metabolite, norzimeldine. | 1983 | 5 |
| 11 | [Regional myocardial perfusion redistribution through coronary drugs. II. Influence of dipyridamole and oxyfedrin on regional perfusion distribution]. | 1976 | 0 |
About A. Wahlén
A. Wahlén is a scholar working on Pharmacology, Toxicology, Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cognitive Neuroscience, having authored 11 papers that have together received 745 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (4 papers), Forensic Toxicology and Drug Analysis (3 papers), Schizophrenia research and treatment (2 papers), Bipolar Disorder and Treatment (2 papers), Neonatal Health and Biochemistry (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Cardiac electrophysiology and arrhythmias (1 paper) and Venous Thromboembolism Diagnosis and Management (1 paper). The work is most often cited by research in Toxicology (165 citations), Pharmacology (528 citations), Cellular and Molecular Neuroscience (205 citations), Biological Psychiatry (15 citations) and Psychiatry and Mental health (88 citations). A. Wahlén has collaborated with scholars based in Sweden, United States and Finland. Frequent co-authors include Stig Agurell, Leo E. Hollister, Annika Ohlsson, J.‐E. Lindgren, H. K. Gillespie, Lars Farde, Paul Jansson, F.‐A. Wiesel, Göran Sedvall and Agneta Ohlsson. Their work appears in journals such as Clinical Pharmacokinetics, Journal of Mass Spectrometry, Acta Anaesthesiologica Scandinavica, The Journal of Clinical Pharmacology and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.